JODI BODENHAMER: Open Payments
NPI 1063162287 · MOUNTAIN HOME, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 25 payments from 10 companies in 2025. Trend: 2023 $959 · 2024 $187 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| Tandem Diabetes Care, Inc. | 7 | $80 |
| Dexcom, Inc. | 2 | $62 |
| Averitas Pharma Inc. | 3 | $60 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| SANOFI-AVENTIS U.S. LLC | 2 | $35 |
| GE HEALTHCARE | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| BETA BIONICS, INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Rybelsus, Dexcom G6 Transmitter, QUTENZA, FARXIGA, TZIELD, GVOKE HYPOPEN, iLet Bionic Pancreas.
Industry payments across AR — which companies pay providers there.
